Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
July-2019 Volume 18 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2019 Volume 18 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Differential clinical benefits of continuous blood purification treatment in critically ill patients with variable APACHE II scores

  • Authors:
    • Rui‑Xiang Zhou
    • Wei Dai
    • Chao‑Liang Hu
  • View Affiliations / Copyright

    Affiliations: Intensive Care Unit of The First Hospital of Wuhan, Wuhan, Hubei 430022, P.R. China
  • Pages: 741-746
    |
    Published online on: May 28, 2019
       https://doi.org/10.3892/etm.2019.7617
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study aimed to assess whether the Acute Physiology And Chronic Health Evaluation (APACHE) II score may be used to predict whether critically ill patients benefit from continuous blood purification (CBP) treatment. A total of 115 critically ill patients were retrospectively reviewed and grouped according to their baseline APACHE II scores. Each group was further divided into 2 groups based on whether they received CBP or not. At 72 h after CBP treatment, clinical indicators comprising the plasma levels of inflammatory cytokines, including tumor necrosis factor (TNF)‑α, interleukin (IL)‑6 and IL‑8, as well as endotoxin and procalcitonin (PCT), and severity scores (APACHE II, multiple organ dysfunction syndrome and systemic inflammatory response syndrome), were analyzed in all patients. It was observed that while CBP slightly reduced the severity scores in all patients, it significantly improved those in patients with an APACHE II score of 20‑29 (P<0.05). Similarly, the plasma levels of TNF‑α, IL‑6, IL‑8, endotoxin and PCT were significantly lower in patients receiving CBP than in those without CBP when the APACHE II score was 20‑29 (P<0.05). Furthermore, CBP treatment significantly decreased the fatality rate and length of stay at the intensive care unit (ICU) for critically ill patients with an APACHE II score of 20‑29 (P<0.05). In conclusion, CBP significantly decreases the inflammatory response, shortens the length of stay at the ICU and improves the prognosis for critically ill patients with an APACHE II score of 20‑29 points. This observation suggests that the APACHE II score is an important clinical indicator to determine the potential benefit of CBP therapy in critically ill patients.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Gong H, Sheng X, Xue J and Zhu D: Expression and role of TNIP2 in multiple organ dysfunction syndrome following severe trauma. Mol Med Rep. 19:2906–2912. 2019.PubMed/NCBI

2 

Jastrow KM III, Gonzalez EA, McGuire MF, Suliburk JW, Kozar RA, Iyengar S, Motschall DA, McKinley BA, Moore FA and Mercer DW: Early cytokine production risk stratifies trauma patients for multiple organ failure. J Am Coll Surg. 209:320–331. 2009. View Article : Google Scholar : PubMed/NCBI

3 

Saadia R and Schein M: Multiple organ failure. How valid is the ‘two hit’ model? J Accid Emerg Med. 16:163–167. 1999. View Article : Google Scholar

4 

Yao YM, Redl H, Bahrami S and Schlag G: The inflammatory basis of trauma/shock-associated multiple organ failure. Inflamm Res. 47:201–210. 1998. View Article : Google Scholar : PubMed/NCBI

5 

St John RC and Dorinsky PM: Immunologic therapy for ARDS, septic shock, and multiple-organ failure. Chest. 103:932–943. 1993. View Article : Google Scholar : PubMed/NCBI

6 

Hanafusa N: Application of continuous replacement therapy: What should we consider based on existing evidence? Blood Purif. 40:312–319. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Intensive Care Society: Standards and recommendations for the provision of renal replacement therapy on intensive care units in the United Kingdom. Intensive Care Society. 2009.

8 

Lee S, Hwang H, Yamal JM, Goodman JC, Aisiku IP, Gopinath S and Robertson CS: IMPACT probability of poor outcome and plasma cytokine concentrations are associated with multiple organ dysfunction syndrome following traumatic brain injury. J Neurosurg. Jan 11–2019.(Epub ahead of print). View Article : Google Scholar

9 

Finkel KW and Podoll AS: Complications of continuous renal replacement therapy. Semin Dial. 22:155–159. 2009. View Article : Google Scholar : PubMed/NCBI

10 

Cheng J, Hu S, Lu H, Lei Q, Liu J, Yuan F and Chen R: Comparison of the therapeutic effectiveness of sustained low-efficiency dialysis (SLED) with continuous blood purification (CBP) in critically ill patients. Cell Biochem Biophys. 67:923–927. 2013. View Article : Google Scholar : PubMed/NCBI

11 

Dehghani A, Abdeyazdan G and Davaridolatabadi E: An overview of the predictor standard tools for patient weaning from mechanical ventilation. Electron Physician. 8:1955–1963. 2016. View Article : Google Scholar : PubMed/NCBI

12 

Sadaka F, EthmaneAbouElMaali C, Cytron MA, Fowler K, Javaux VM and O'Brien J: Predicting mortality of patients with sepsis: A comparison of APACHE II and APACHE III scoring systems. J Clin Med Res. 9:907–910. 2017. View Article : Google Scholar : PubMed/NCBI

13 

Baue E: MOF, MODS, and SIRS: What is in a name or an acronym? Shock. 26:438–449. 2006. View Article : Google Scholar : PubMed/NCBI

14 

Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL and Sibbald WJ: Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit Care Med. 23:1638–1652. 1995. View Article : Google Scholar : PubMed/NCBI

15 

Baek JH, Kim MS, Lee JC and Lee JH: Systemic inflammation response syndrome score predicts the mortality in multiple trauma patients. Korean J Thorac Cardiovasc Surg. 47:523–528. 2014. View Article : Google Scholar : PubMed/NCBI

16 

NeSmith EG, Weinrich SP, Andrews JO, Medeiros RS, Hawkins ML and Weinrich M: Systemic inflammatory response syndrome score and race as predictors of length of stay in the intensive care unit. Am J Crit Care. 18:339–346. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Knaus WA, Draper EA, Wagner DP and Zimmerman JE: APACHE II: A severity of disease classification system. Crit Care Med. 13:818–829. 1985. View Article : Google Scholar : PubMed/NCBI

18 

Jacobs S, Zuleika M and Mphansa T: The multiple organ dysfunction score as a descriptor of patient outcome in septic shock compared with two other scoring systems. Crit Care Med. 27:741–744. 1999. View Article : Google Scholar : PubMed/NCBI

19 

Zhou Z, Guo F and Huan J: Fournier's gangrene with septic shock and multiple organ dysfunction syndrome. Int J Low Extrem Wounds. 18:94–96. 2019. View Article : Google Scholar : PubMed/NCBI

20 

Zeng J: Values of detection of NF-κB activation level combined with IL-6 and TNF-α levels in peripheral neutrophils in the prediction of multiple organ dysfunction syndrome in patients with severe multiple trauma. Exp Ther Med. 16:2478–2482. 2018.PubMed/NCBI

21 

Wang F, Guan X, Yang J, He W, Wei Y, Chen H and Li Y: Differential expression and significance of endoplasmic reticulum golgi intermediate compartment 1 in precancerous gastric lesions and gastric cancer. Am J Med Sci. 355:228–234. 2018. View Article : Google Scholar : PubMed/NCBI

22 

Li A, Xiong J and Chen Z: IL-6, TNF-α, and iNOS is associated with decreased colonic contraction in rats with multiple organ dysfunction syndrome. J Surg Res. 178:e51–e57. 2012. View Article : Google Scholar : PubMed/NCBI

23 

Lee JH, Kim HY, Bae EH, Kim SW and Ma SK: Biomarkers predicting survival of sepsis patients treated with continuous renal replacement therapy. Chonnam Med J. 53:64–68. 2017. View Article : Google Scholar : PubMed/NCBI

24 

Shimazui T, Matsumura Y, Nakada TA and Oda S: Serum levels of interleukin-6 may predict organ dysfunction earlier than SOFA score. Acute Med Surg. 4:255–261. 2017. View Article : Google Scholar : PubMed/NCBI

25 

Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, Rubenfeld G, Kahn JM, Shankar-Hari M, Singer M, et al: Assessment of clinical criteria for sepsis: For the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 315:762–774. 2016. View Article : Google Scholar : PubMed/NCBI

26 

Lee YJ, Park CH, Yun JW and Lee YS: Predictive comparisons of procalcitonin (PCT) level, arterial ketone body ratio (AKBR), APACHE III score and multiple organ dysfunction score (MODS) in systemic inflammatory response syndrome (SIRS). Yonsei Med J. 45:29–37. 2004. View Article : Google Scholar : PubMed/NCBI

27 

Ávalos-López M, Pérez-López MJ, Aguilar-Martínez C, Díaz-Franco AMC, Esquivel-Chávez A and Baltazar-Torres JA: Prediction of acute kidney injury in critically ill patients treated with intermittent hemodialysis versus CRRT. Rev Med Inst Mex Seguro Soc. 55:696–703. 2017.(In Spanish). PubMed/NCBI

28 

Yoon J, Kim Y, Kym D, Hur J, Yim H, Cho YS and Chun W: Subgroup analysis of continuous renal replacement therapy in severely burned patients. PLoS One. 12:e01890572017. View Article : Google Scholar : PubMed/NCBI

29 

Li YN, Zhou LX, Qiang XH, Yu TO, Mao KJ, Feng B, Wen WB, Zou YC, Li WY and Li C: Effect of continuous blood purification and thymosin alpha1 on the cellular immunity in patients with severe sepsis: A prospective, randomized, controlled clinical trial. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 21:139–142. 2009.PubMed/NCBI

30 

Zhou R, Weng F, Dai W and Yan J: The organ protective effects and timing of continuous blood purification in the treatment of severe sepsis: A double-blind randomized controlled trial. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 28:241–245. 2006.(In Chinese).

31 

Sabatino A, Theilla M, Hellerman M, Singer P, Maggiore U, Barbagallo M, Regolisti G and Fiaccadori E: Energy and protein in critically ill patients with AKI: A prospective, multicenter observational study using indirect calorimetry and protein catabolic rate. Nutrients. 9(pii): E8022017. View Article : Google Scholar : PubMed/NCBI

32 

Allegretti AS, Steele DJ, David-Kasdan JA, Bajwa E, Niles JL and Bhan I: Continuous renal replacement therapy outcomes in acute kidney injury and end-stage renal disease: A cohort study. Crit Care. 17:R1092013. View Article : Google Scholar : PubMed/NCBI

33 

Quinto BM, Iizuka IJ, Monte JC, Santos BF, Pereira V, Durão MS, Dalboni MA, Cendoroglo M, Santos OF and Batista MC: TNF-α depuration is a predictor of mortality in critically ill patients under continuous veno-venous hemodiafiltration treatment. Cytokine. 71:255–260. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhou RX, Dai W and Hu CL: Differential clinical benefits of continuous blood purification treatment in critically ill patients with variable APACHE II scores. Exp Ther Med 18: 741-746, 2019.
APA
Zhou, R., Dai, W., & Hu, C. (2019). Differential clinical benefits of continuous blood purification treatment in critically ill patients with variable APACHE II scores. Experimental and Therapeutic Medicine, 18, 741-746. https://doi.org/10.3892/etm.2019.7617
MLA
Zhou, R., Dai, W., Hu, C."Differential clinical benefits of continuous blood purification treatment in critically ill patients with variable APACHE II scores". Experimental and Therapeutic Medicine 18.1 (2019): 741-746.
Chicago
Zhou, R., Dai, W., Hu, C."Differential clinical benefits of continuous blood purification treatment in critically ill patients with variable APACHE II scores". Experimental and Therapeutic Medicine 18, no. 1 (2019): 741-746. https://doi.org/10.3892/etm.2019.7617
Copy and paste a formatted citation
x
Spandidos Publications style
Zhou RX, Dai W and Hu CL: Differential clinical benefits of continuous blood purification treatment in critically ill patients with variable APACHE II scores. Exp Ther Med 18: 741-746, 2019.
APA
Zhou, R., Dai, W., & Hu, C. (2019). Differential clinical benefits of continuous blood purification treatment in critically ill patients with variable APACHE II scores. Experimental and Therapeutic Medicine, 18, 741-746. https://doi.org/10.3892/etm.2019.7617
MLA
Zhou, R., Dai, W., Hu, C."Differential clinical benefits of continuous blood purification treatment in critically ill patients with variable APACHE II scores". Experimental and Therapeutic Medicine 18.1 (2019): 741-746.
Chicago
Zhou, R., Dai, W., Hu, C."Differential clinical benefits of continuous blood purification treatment in critically ill patients with variable APACHE II scores". Experimental and Therapeutic Medicine 18, no. 1 (2019): 741-746. https://doi.org/10.3892/etm.2019.7617
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team